191 related articles for article (PubMed ID: 17094994)
1. Statin-associated adverse effects beyond muscle and liver toxicity.
Kiortsis DN; Filippatos TD; Mikhailidis DP; Elisaf MS; Liberopoulos EN
Atherosclerosis; 2007 Nov; 195(1):7-16. PubMed ID: 17094994
[TBL] [Abstract][Full Text] [Related]
2. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Turkoski BB
Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
[TBL] [Abstract][Full Text] [Related]
3. Statin safety: lessons from new drug applications for marketed statins.
Jacobson TA
Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
[TBL] [Abstract][Full Text] [Related]
4. Statin safety: an overview and assessment of the data--2005.
Bays H
Am J Cardiol; 2006 Apr; 97(8A):6C-26C. PubMed ID: 16581330
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and dangers of statin therapy.
Maritz FJ
Cardiovasc J S Afr; 2002; 13(4):200-3. PubMed ID: 12389064
[TBL] [Abstract][Full Text] [Related]
6. Statins and plaque stability.
Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
[TBL] [Abstract][Full Text] [Related]
7. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
Geng Q; Ren J; Chen H; Lee C; Liang W
Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
[TBL] [Abstract][Full Text] [Related]
8. A clinical review of statins and cancer: helpful or harmful?
Gonyeau MJ; Yuen DW
Pharmacotherapy; 2010 Feb; 30(2):177-94. PubMed ID: 20099992
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
Kostapanos MS; Milionis HJ; Elisaf MS
Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
[TBL] [Abstract][Full Text] [Related]
10. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.
Jacobson TA
Mayo Clin Proc; 2008 Jun; 83(6):687-700. PubMed ID: 18533086
[TBL] [Abstract][Full Text] [Related]
11. Statins and cancer prevention.
Demierre MF; Higgins PD; Gruber SB; Hawk E; Lippman SM
Nat Rev Cancer; 2005 Dec; 5(12):930-42. PubMed ID: 16341084
[TBL] [Abstract][Full Text] [Related]
12. The controversies of statin therapy: weighing the evidence.
Jukema JW; Cannon CP; de Craen AJ; Westendorp RG; Trompet S
J Am Coll Cardiol; 2012 Sep; 60(10):875-81. PubMed ID: 22902202
[TBL] [Abstract][Full Text] [Related]
13. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
Igel M; Sudhop T; von Bergmann K
Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
[TBL] [Abstract][Full Text] [Related]
14. Are statins really wonder drugs?
Grover HS; Luthra S; Maroo S
J Formos Med Assoc; 2014 Dec; 113(12):892-8. PubMed ID: 24231094
[TBL] [Abstract][Full Text] [Related]
15. Statins and myotoxicity.
Farmer JA
Curr Atheroscler Rep; 2003 Mar; 5(2):96-100. PubMed ID: 12573193
[TBL] [Abstract][Full Text] [Related]
16. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
Chen YW; Lai HW; Wang TD
Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
[TBL] [Abstract][Full Text] [Related]
17. Managing statin-induced muscle toxicity in a lipid clinic.
Blaier O; Lishner M; Elis A
J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
[TBL] [Abstract][Full Text] [Related]
18. Effects of statins on renal function.
Agarwal R
Am J Cardiol; 2006 Mar; 97(5):748-55. PubMed ID: 16490450
[TBL] [Abstract][Full Text] [Related]
19. Safety of statins.
Brown WV
Curr Opin Lipidol; 2008 Dec; 19(6):558-62. PubMed ID: 18957877
[TBL] [Abstract][Full Text] [Related]
20. Statin use and cancer risk: an epidemiologic review.
Friis S; Olsen JH
Cancer Invest; 2006; 24(4):413-24. PubMed ID: 16777695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
